People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those ...

The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...

Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and ...

It's yet another perk of these medications.

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.